H79TI085739
Project Grant
Overview
Grant Description
Arizona State Opioid Response Grant III (FY2022) - The overarching goal of the project is to increase access to medications for the treatment of opiate use disorder (MOUD), coordinated and integrated care, and recovery support services to reduce the prevalence of OUDs, stimulant use disorder, and stimulant/opioid related overdose deaths in the state of Arizona.
The project approach includes developing and supporting state, regional, and local level collaborations, substance use disorder (SUD) prevention programming, and service enhancements that enact evidence-based practices. These practices comprehensively address the full continuum of care related to stimulant and opioid misuse, abuse, and dependence.
The primary populations of focus for the Arizona State Opioid Response (SOR) grant are as follows:
- Individuals with active opioid use
- Individuals with opioid use disorder (OUD)
- Individuals at risk for opioid overdose or misuse
- Individuals with stimulant use disorder
- Individuals in recovery
- Youth confronted with social pressures related to opioids/stimulants
- Youth, parents, community members, and health consumers unaware of the potential risks of opioid/stimulant misuse and abuse
Arizona has also identified the following sub-populations for targeted activities in SOR:
- Individuals re-entering the community from correctional settings
- Individuals in rural and isolated areas
- Individuals without housing or with insecure housing
- Tribal populations
- Veterans, military service members, and military families
- Pregnant women and parents with OUD, especially those with matters in family court or with Department of Child Safety involvement
- Individuals with physical disabilities
- Individuals needing pain management
- Individuals who have experienced trauma, toxic stress, or adverse childhood experiences (ACES)
Although funding will be used in part to address stimulant use, the bulk of focus remains on opioid misuse.
The project aims to serve 4,000,000 unduplicated individuals between year one and year two under prevention activities. Additionally, it will serve 5,750 unduplicated individuals with treatment and recovery services in year one and an additional 6,500 unduplicated individuals in year two, resulting in a total project reach of 12,250 unduplicated individuals. Of those individuals receiving treatment and recovery support services, 5,000 individuals will complete the CSAT GPRA tool (2,200 intakes in year one and 2,800 in year two).
The project approach includes developing and supporting state, regional, and local level collaborations, substance use disorder (SUD) prevention programming, and service enhancements that enact evidence-based practices. These practices comprehensively address the full continuum of care related to stimulant and opioid misuse, abuse, and dependence.
The primary populations of focus for the Arizona State Opioid Response (SOR) grant are as follows:
- Individuals with active opioid use
- Individuals with opioid use disorder (OUD)
- Individuals at risk for opioid overdose or misuse
- Individuals with stimulant use disorder
- Individuals in recovery
- Youth confronted with social pressures related to opioids/stimulants
- Youth, parents, community members, and health consumers unaware of the potential risks of opioid/stimulant misuse and abuse
Arizona has also identified the following sub-populations for targeted activities in SOR:
- Individuals re-entering the community from correctional settings
- Individuals in rural and isolated areas
- Individuals without housing or with insecure housing
- Tribal populations
- Veterans, military service members, and military families
- Pregnant women and parents with OUD, especially those with matters in family court or with Department of Child Safety involvement
- Individuals with physical disabilities
- Individuals needing pain management
- Individuals who have experienced trauma, toxic stress, or adverse childhood experiences (ACES)
Although funding will be used in part to address stimulant use, the bulk of focus remains on opioid misuse.
The project aims to serve 4,000,000 unduplicated individuals between year one and year two under prevention activities. Additionally, it will serve 5,750 unduplicated individuals with treatment and recovery services in year one and an additional 6,500 unduplicated individuals in year two, resulting in a total project reach of 12,250 unduplicated individuals. Of those individuals receiving treatment and recovery support services, 5,000 individuals will complete the CSAT GPRA tool (2,200 intakes in year one and 2,800 in year two).
Funding Goals
ADDRESSING THE OPIOID ABUSE CRISIS WITHIN SUCH STATES, USED FOR CARRYING OUT ACTIVITIES THAT SUPPLEMENT ACTIVITIES PERTAINING TO OPIOIDS UNDERTAKEN BY THE STATE AGENCY RESPONSIBLE FOR ADMINISTERING THE SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT UNDER SUBPART II OF PART B OF TITLE XIX OF THE PUBLIC HEALTH SERVICE ACT (42 U.S.C. 300X21 ET SEQ.), AND TRIBES AND TRIBAL ORGANIZATIONS TO ADDRESS THE OPIOID CRISIS WITHIN THEIR COMMUNITIES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Phoenix,
Arizona
85034
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 09/29/24 to 09/29/25 and the total obligations have increased 103% from $31,963,651 to $65,043,713.
Arizona Health Care Cost Containment System was awarded
Arizona State Opioid Response III (FY2022) - Increasing Access to Medications & Coordinated Care
Project Grant H79TI085739
worth $65,043,713
from the Division of Grants Management in September 2022 with work to be completed primarily in Phoenix Arizona United States.
The grant
has a duration of 3 years and
was awarded through assistance program 93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance.
The Project Grant was awarded through grant opportunity State Opioid Response Grants.
Status
(Complete)
Last Modified 1/21/25
Period of Performance
9/30/22
Start Date
9/29/25
End Date
Funding Split
$65.0M
Federal Obligation
$0.0
Non-Federal Obligation
$65.0M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for H79TI085739
Transaction History
Modifications to H79TI085739
Additional Detail
Award ID FAIN
H79TI085739
SAI Number
H79TI085739-2584847665
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75SAMH SAMHSA DIVISION OF GRANTS MANAGEMENT
Funding Office
75MT00 SAMHSA CENTER FOR SUBSTANCE ABUSE TREATMENT
Awardee UEI
LJGVPF5ULHJ3
Awardee CAGE
3W3R6
Performance District
AZ-03
Senators
Kyrsten Sinema
Mark Kelly
Mark Kelly
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Substance Abuse Treatment, Substance Abuse and Mental Health Administration, Health and Human Services (075-1364) | Health care services | Grants, subsidies, and contributions (41.0) | $65,043,713 | 100% |
Modified: 1/21/25